ArticleAntiviral research2014

Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model.

Justin G Julander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.